Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about IONS

Recent news which mentions IONS

< Previous 1 2 3 4 5 Next >
10 Health Care Stocks Whale Activity In Today's Session
Tickers AMGN CI DOCS HIMS
Tags RGEN JANX PFE
From Benzinga
A Glimpse Into The Expert Outlook On Ionis Pharmaceuticals Through 5 Analysts
Tickers IONS
Tags Market News Benzinga BZI/AAR
From Benzinga
Where Ionis Pharmaceuticals Stands With Analysts
Tickers IONS
Tags Market News Benzinga IONS
From Benzinga
Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500
Tickers ADPT ARKG ARKK CDNA
Tags Stories That Matter ARKK CRSP
From Benzinga
Deep Dive Into Ionis Pharmaceuticals Stock: Analyst Perspectives (13 Ratings)
Tickers IONS
Tags Analyst Ratings BZI/AAR IONS
From Benzinga
Rubrik Reports Q2 Results, Joins Ionis Pharmaceuticals, Hewlett Packard Enterprise And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Tickers APLD DBX EXTR HPE
Tags EXTR APLD big gainers
From Benzinga
Why Oracle Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
Tickers AMZN ASNS AVO CNET
Tags SMTK Trading Ideas Pre/Market Outlook
From Benzinga
What 14 Analyst Ratings Have To Say About Ionis Pharmaceuticals
Tickers IONS
Tags Analyst Ratings IONS BZI/AAR
From Benzinga
12 Analysts Have This To Say About Ionis Pharmaceuticals
Tickers IONS
Tags Analyst Ratings BZI/AAR IONS
From Benzinga
Ionis' Rare Development Disorder Drug Candidate 'Could Be Differentiated' From Peer Ultragenyx: Analyst
Tickers ALNY AZN BIIB IONS
Tags IONS RARE General
From Benzinga
The Latest Analyst Ratings For Ionis Pharmaceuticals
Tickers IONS
Tags Benzinga Market News Analyst Ratings
From Benzinga
Assessing Ionis Pharmaceuticals: Insights From 6 Financial Analysts
Tickers IONS
Tags Benzinga Market News Analyst Ratings
From Benzinga
RXO, Alnylam Pharmaceuticals And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Tickers ALNY ALT ARGX CLOV
Tags ARGX Premarket Movers IONS
From Benzinga
Deep Dive Into Ionis Pharmaceuticals Stock: Analyst Perspectives (6 Ratings)
Tickers IONS
Tags Analyst Ratings BZI/AAR IONS
From Benzinga
Ionis Pharmaceuticals Reveals Late-Stage Donidalorsen Data, Analyst Says Results Show Competitive Hereditary Angioedema Profile
Tickers IONS NEWS
Tags Trading Ideas Reiteration Health Care
From Benzinga
Europe Approves Biogen's Tofersen For Adult Patients With Rare Type Of Neurodegenerative Disorder
Tickers BIIB IONS NEWS
Tags Top Stories Health Care News
From Benzinga
Tale Of Two Ionis-Partnered Neurology-Focused Early Stage Assets-Biogen Discontinues One, Decides Not To Exercise Licensing Option For Another
Tickers BIIB IONS NEWS
Tags Health Care Trading Ideas Large Cap
From Benzinga
The 3 Most Undervalued Pharma Stocks to Buy in May 2024
Tickers BIIB IONS SNY
Tags Stocks to Buy SNY BIIB
From InvestorPlace
The Analyst Landscape: 8 Takes On Ionis Pharmaceuticals
Tickers IONS
Tags Analyst Ratings BZI/AAR IONS
From Benzinga
IONS Stock Earnings: Ionis Pharmaceuticals Beats EPS, Misses Revenue for Q1 2024
Tickers IONS
Tags Market News Earnings Reports NASDAQ:IONS
From InvestorPlace
The Latest Analyst Ratings For Ionis Pharmaceuticals
Tickers IONS
Tags Benzinga Market News BZI/AAR
From Benzinga
Genetic Medicines Focused-Ionis Pharmaceuticals' Fatty Liver Candidate Lowers Excess Liver Fat, Midstage Study Data Shows
Tickers IONS NEWS
Tags General IONS Benzinga
From Benzinga
Cracking The Code: Understanding Analyst Reviews For Ionis Pharmaceuticals
Tickers IONS
Tags IONS BZI/AAR Analyst Ratings
From Benzinga
Earnings Scheduled For February 21, 2024
Tickers ACVA ADI AGI AGR
Tags GNW UIS ECPG
From Benzinga
JP Morgan Maintains Neutral Rating for Ionis Pharmaceuticals: Here's What You Need To Know
Tickers IONS
Tags Analyst Ratings IONS BZI/AAR/UPDATE
From Benzinga
Biogen Gives Up On Aduhelm Efforts After Two Years Of Controversial FDA Accelerated Approval For Alzheimer's, Shifts Focus On Newer Medicines
Tickers BIIB IONS NEWS
Tags Briefs Stories That Matter Alzheimer's disease
From Benzinga
Rare Disease Focused Ionis Pharmaceuticals Gears Up for FDA Submission After Donidalorsen Outperforms Placebo In Swollen Vessels Study
Tickers IONS NEWS
Tags Reiteration Trading Ideas Health Care
From Benzinga
Expert Outlook: Ionis Pharmaceuticals Through The Eyes Of 8 Analysts
Tickers IONS
Tags Benzinga Market News IONS
From Benzinga
2024 And Beyond – Exploring Six Investment Megatrends With Tema ETFs
Tickers ALNY ARM CPRI IONS
Tags Market News ARM MRK
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Tickers ABBV ALNY CVS GILD
Tags Benzinga PFE IONS
From Benzinga
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.